DD vs DMAC
Dupont De Nemours Inc (DD) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
DMAC does not have a complete income-statement cache yet.
DD currently screens at market cap $19.61B and trailing P/E 127.4. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the DD and DMAC stock pages for the full models.
Not investment advice.